Markets Earnings Screener Watchlist

Fundamentals and filings are sourced from SEC EDGAR. Market data, ownership and analyst consensus are sourced from Nasdaq. Written analysis is generated by metir from those sources and the linked reporting.

All information is provided for informational purposes only. It is not investment, financial, tax or legal advice, is not a recommendation to buy or sell any security, and is not intended for trading purposes. Data may be delayed or incomplete.

Markets open

Alnylam Pharmaceuticals, Inc. Stock Price: Quote, Financials, Forecast & News (ALNY)

Alnylam Pharmaceuticals, Inc.

ALNY · NASDAQ-GS

Overview Financials Earnings Holders Historical Data Analysis

Symbol: ALNY
Type: Stock
Sector: Health Care
Industry: Biotechnology: Pharmaceutical Preparations
Country: North America
Exchange: NASDAQ-GS

Alnylam (Nasdaq: ALNY) is a leading global biopharmaceutical company and the pioneer of the RNA interference (RNAi) revolution. The Company is focused on developing transformative therapies with the potential to prevent, halt, or reverse disease. For more than two decades, Alnylam has advanced the Nobel-prize-winning science of RNAi, delivering critical breakthroughs and six approved medicines. Alnylam has medicines available in more than 70 countries and a rapidly expanding and robust pipeline, in addition to consistently being recognized as an exceptional workplace and socially responsible organization. The Company is executing on its Alnylam 2030 strategy to accelerate innovation and scale impact to transform human health.

Analyst Consensus

Buy

26 analysts

$228

Current

—

Low

$375

Average

—

High

Average target implies +64.45% versus the current price.

Earnings History

BeatMissNo estimate

Peers

Biogen Inc.BIIB · NASDAQ-GS$208.21

0.12%

Zoetis Inc.ZTS · NYSE$74.092.56%

Royalty Pharma plc Class A Ordinary Shares RPRX · NASDAQ-GS$57.660.31%

BeOne Medicines Ltd. American Depositary SharesONC · NASDAQ-GS$329.381.97%

$228.03+$9.034.12%

As of: Aug 5, 6:12 PM

Prev Close: $219.00
Market Cap: $30.51B
Open: —
Trailing P/E: —
Day Range: $229.65 - $221.50
52W Range: $495.55 - $197.81
Forward P/E: —
EPS: —
Volume: 1.28M
Dividend Yield: —

Notable Price Movement

Weekly movement commentary will appear here once it has been generated for this company.

Stories & Analysis

Alnylam (ALNY) Q2 2026 Earnings Call Transcript

The Motley Fool · 2d ago

ALNY Stock Tanks 28% as Q2 Earnings Miss Estimates, '26 Sales View Cut

Zacks · 5d ago

Alnylam Pharma (ALNY) Q2 2026 Earnings Call Transcript

The Motley Fool · 6d ago

Alnylam Falls 29% After Reporting Q2 Results

RTTNews · 6d ago

IBB, REGN, ARGX, ALNY: Large Outflows Detected at ETF

BNK Invest · 6d ago Nasdaq 100 Movers: ALNY, NBIS

BNK Invest · 6d ago Alnylam Pharmaceuticals Q2 Earnings Call Highlights

MarketBeat · 6d ago Alnylam (ALNY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks · 6d ago

Beta

—

Avg Volume

1.64M